Vimarsana
Biggest News Aggregation in the World

Page 2 - Precision Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Bioscience Today - Breaking & Trending Today

Specific Biologics Strengthens Scientific Advisory Board with Appointment of Tirtha Chakraborty, Ph.D. and Mike Nicholson, Ph.D. - Vimarsana News

Specific Biologics Strengthens Scientific Advisory Board with Appointment of Tirtha Chakraborty, Ph.D. and Mike Nicholson, Ph.D.

/PRNewswire/ - Specific Biologics Inc. ("Specific"), a venture-backed, early-stage genome editing company, is pleased to announce it has appointed Tirtha...

Mesoblast (NASDAQ:MESO) & Precision BioSciences (NASDAQ:DTIL) Critical Survey - Vimarsana News

Mesoblast (NASDAQ:MESO) & Precision BioSciences (NASDAQ:DTIL) Critical Survey

Mesoblast (NASDAQ:MESO – Get Rating) and Precision BioSciences (NASDAQ:DTIL – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership. Profitability This table compares Mesoblast and Precision BioSciences’ net margins, […]

Source: wkrb13.com
Comparing Amgen (NASDAQ:AMGN) & Precision BioSciences (NASDAQ:DTIL) - Vimarsana News

Comparing Amgen (NASDAQ:AMGN) & Precision BioSciences (NASDAQ:DTIL)

Amgen (NASDAQ:AMGN – Get Rating) and Precision BioSciences (NASDAQ:DTIL – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation. Volatility & Risk Amgen has a beta of 0.64, meaning that […]

FY2026 EPS Estimates for Precision BioSciences, Inc. Reduced by HC Wainwright (NASDAQ:DTIL) - Vimarsana News

FY2026 EPS Estimates for Precision BioSciences, Inc. Reduced by HC Wainwright (NASDAQ:DTIL)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

SpringWorks Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights - Vimarsana News

SpringWorks Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights

04.08.2022 - – Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors Met Its Primary and All Key Secondary Endpoints – – Encouraging Preliminary Data from Phase 1/2 Study Evaluating Nirogacestat in Combination with ...